Cognivix, a Human-Mimicking Robot for Industrial Automation, Launches an Equity Crowdfunding Round

Cognivix, an Italian startup founded in 2021, has developed a technology that allows industrial robots to learn and replicate assembly processes by observing a human.

The company has launched an equity crowdfunding campaign on Mamacrowd which, to date, has raised more than 400,000 euros, thus far exceeding the minimum target of 150,000 euros.

The round starts at a pre-money valuation of $3 million and has already attracted interest from over 170 investors. At the beginning of 2023, the startup had launched a first successful campaign that had raised 127,000 euros on the Backtowork platform, with a pre-money valuation of 2.5 million.

Cognivix- Specific solutions to solve complex automation problems

Cognivix, founded by Daniele Bernardini, a former researcher at the Technical University of Munich, and a team of experts, is developing specific solutions to solve complex automation problems, such as the manipulation of laser-cut objects and the automation of welding. The full platform is scheduled for launch in 2028.

Cognivix’s system integrates three key components: 3D vision, which allows the robot to identify and manipulate objects in real time; imitation learning , which allows the robot to learn simply by observing; and force feedback, which provides the precision needed for delicate operations.

Thanks to this technology, companies can automate very complicated processes such as the assembly of plastic and metal components in the electronics, automotive, cosmetics, etc. sectors, reducing labor costs.

Awards and collaborations

Cognivix was recently selected as one of the top 20 startups to watch in global manufacturing by StartUS Insights, and was included in the prestigious NVIDIA Inception Program.

The company partners with industry leaders such as FANUC and NTT Data, and its software is scalable, integrating with existing hardware, making the technology easily adoptable by companies around the world.

Daniele Bernardini, CEO and Founder of Cognivix, explained: “Our technology has the potential to revolutionize industrial automation, but to realize this vision we need to accelerate our growth globally. The expansion into the United States is a key milestone for us, and we are excited to announce that we are moving our company headquarters to Silicon Valley. ”

How the funds raised will be used

The funds raised through the equity crowdfunding campaign on Mamacrowd will be used to commercialize vertical solutions, allowing companies to begin adopting technology with more accessible and immediate applications.

Additionally, through the support of strategic partners and participation in acceleration programs, Cognivix is ​​expanding its presence, with a particular focus on international growth, including the European and American markets.

__

(Featured image by Possessed Photography via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Crowdfunding buzz. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.